LT3386997T - Monomaleimidu funkcionalizuoti platinos junginiai, skirti vėžio terapijai - Google Patents
Monomaleimidu funkcionalizuoti platinos junginiai, skirti vėžio terapijaiInfo
- Publication number
- LT3386997T LT3386997T LTEPPCT/EP2016/080453T LT16080453T LT3386997T LT 3386997 T LT3386997 T LT 3386997T LT 16080453 T LT16080453 T LT 16080453T LT 3386997 T LT3386997 T LT 3386997T
- Authority
- LT
- Lithuania
- Prior art keywords
- monomaleimide
- functioned
- cancer therapy
- platinum compounds
- platinum
- Prior art date
Links
- 229940045985 antineoplastic platinum compound Drugs 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
- 150000003058 platinum compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15198739 | 2015-12-09 | ||
| PCT/EP2016/080453 WO2017097986A1 (en) | 2015-12-09 | 2016-12-09 | Monomaleimide-functionalized platinum compounds for cancer therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3386997T true LT3386997T (lt) | 2021-12-10 |
Family
ID=54849106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/EP2016/080453T LT3386997T (lt) | 2015-12-09 | 2016-12-09 | Monomaleimidu funkcionalizuoti platinos junginiai, skirti vėžio terapijai |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10723748B2 (lt) |
| EP (1) | EP3386997B1 (lt) |
| JP (1) | JP6867652B2 (lt) |
| CN (1) | CN108368143B (lt) |
| AU (1) | AU2016367306B2 (lt) |
| CA (1) | CA3004630A1 (lt) |
| CY (1) | CY1124529T1 (lt) |
| DK (1) | DK3386997T3 (lt) |
| ES (1) | ES2898704T3 (lt) |
| HR (1) | HRP20211466T1 (lt) |
| HU (1) | HUE056897T2 (lt) |
| IL (1) | IL259864B (lt) |
| LT (1) | LT3386997T (lt) |
| MX (1) | MX2018006953A (lt) |
| PL (1) | PL3386997T3 (lt) |
| PT (1) | PT3386997T (lt) |
| RS (1) | RS62412B1 (lt) |
| SG (1) | SG11201804885TA (lt) |
| SI (1) | SI3386997T1 (lt) |
| SM (1) | SMT202100709T1 (lt) |
| WO (1) | WO2017097986A1 (lt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101915452B1 (ko) * | 2014-06-23 | 2018-11-06 | 플라콘 테라퓨틱스 인코포레이티드 | 백금 화합물, 조성물 및 이의 용도 |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療 |
| CN109171001A (zh) * | 2018-09-14 | 2019-01-11 | 上海烟草集团有限责任公司 | 草酸钠在降低卷烟烟气中TSNAs释放量中的应用 |
| US20230339997A1 (en) * | 2020-09-11 | 2023-10-26 | Shanghai Haiju Biological Technology Co., Ltd. | Class of platinum compounds for treating cancer, and method for preparation thereof |
| CN114163479A (zh) * | 2020-09-11 | 2022-03-11 | 上海海聚生物科技有限公司 | 一类治疗癌症用的铂类化合物及其制备方法 |
| CN114539320A (zh) * | 2020-11-25 | 2022-05-27 | 北京大学 | 辐射激活的四价铂配合物及其用途 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| CH588505A5 (lt) | 1972-06-08 | 1977-06-15 | Research Corp | |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| ATE12348T1 (de) | 1980-11-10 | 1985-04-15 | Gersonde Klaus Prof Dr | Verfahren zur herstellung von lipid-vesikeln durch ultraschallbehandlung, anwendung des verfahrens und vorrichtung zur durchfuehrung des verfahrens. |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| EP0088046B1 (de) | 1982-02-17 | 1987-12-09 | Ciba-Geigy Ag | Lipide in wässriger Phase |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| JPS607934A (ja) | 1983-06-29 | 1985-01-16 | Dai Ichi Seiyaku Co Ltd | リポソ−ムの製造方法 |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| ATE159858T1 (de) | 1983-09-26 | 1997-11-15 | Ehrenfeld Udo | Mittel und erzeugnis für die diagnose und therapie von tumoren sowie zur behandlung von schwächen der zelligen und humoralen immunabwehr |
| US4615885A (en) | 1983-11-01 | 1986-10-07 | Terumo Kabushiki Kaisha | Pharmaceutical composition containing urokinase |
| CS269719B1 (en) | 1986-12-29 | 1990-05-14 | Kiss Frantisek | Platinum cytostatic |
| US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| DE19636889A1 (de) | 1996-09-11 | 1998-03-12 | Felix Dr Kratz | Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel |
| WO1999016422A1 (en) | 1997-09-29 | 1999-04-08 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| AU761587B2 (en) | 1998-04-21 | 2003-06-05 | Amgen Research (Munich) Gmbh | CD19xCD3 specific polypeptides and uses thereof |
| DE19926154A1 (de) | 1999-06-09 | 2000-12-14 | Ktb Tumorforschungs Gmbh | Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung |
| AUPQ641100A0 (en) | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
| PT1280520E (pt) | 2000-05-10 | 2014-12-16 | Novartis Ag | Pós à base de fosfolípidos para administração de fármacos |
| TWI324518B (en) | 2001-12-19 | 2010-05-11 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
| DE10314780A1 (de) | 2003-03-19 | 2004-09-30 | Ktb Tumorforschungsgesellschaft Mbh | Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden |
| RU2343913C2 (ru) | 2003-03-31 | 2009-01-20 | Плива-Лахема А.С. | Фармацевтическая композиция, содержащая комплекс платины в качестве активного вещества, и способ ее получения |
| CZ296169B6 (cs) | 2004-09-08 | 2006-01-11 | Pliva - Lachema A. S. | Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
| CZ296459B6 (cs) | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
| US20060205810A1 (en) | 2004-11-24 | 2006-09-14 | Schering Corporation | Platinum therapeutic combinations |
| CZ300120B6 (cs) | 2006-06-20 | 2009-02-11 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
| CZ300590B6 (cs) | 2006-06-20 | 2009-06-24 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
| CZ300424B6 (cs) | 2006-06-20 | 2009-05-13 | Pliva - Lachema A. S. | Farmaceutická kompozice pro perorální podání |
| EP2793585A4 (en) | 2011-12-05 | 2015-12-09 | Igenica Biotherapeutics Inc | Antibody-Agent Conjugates and Related Compounds, Compositions and Methods |
| MX366864B (es) * | 2012-02-27 | 2019-07-26 | Amunix Operating Inc | Composiciones de conjugados de xten y métodos para realizarlas. |
| EA201690434A1 (ru) * | 2013-10-08 | 2016-08-31 | Этлас Дженетикс Лимитед | Маркирующие соединения и их применение в анализах |
| EP3089745A4 (en) | 2013-12-31 | 2017-05-17 | Placon Therapeutics, Inc. | Compounds, compositions, and methods for the treatment of cancers |
| KR101915452B1 (ko) * | 2014-06-23 | 2018-11-06 | 플라콘 테라퓨틱스 인코포레이티드 | 백금 화합물, 조성물 및 이의 용도 |
| WO2016209935A1 (en) | 2015-06-23 | 2016-12-29 | Placon Therapeutics, Inc. | Platinum compounds, compositions, and uses thereof |
| US10342801B2 (en) | 2015-06-23 | 2019-07-09 | Placon Therapeutics, Inc. | Platinum compounds, compositions, and uses thereof |
| EP3313527B1 (en) | 2015-06-29 | 2021-02-24 | Case Western Reserve University | Anticancer drug-containing plant virus particles |
| JP6759326B2 (ja) | 2015-07-12 | 2020-09-23 | ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． | 細胞結合分子の共役のための架橋連結体 |
| JP7043425B2 (ja) | 2016-06-06 | 2022-03-29 | ジェネンテック， インコーポレイテッド | シルベストロール抗体－薬物コンジュゲート及び使用方法 |
| CN109690315A (zh) | 2016-07-08 | 2019-04-26 | 豪夫迈·罗氏有限公司 | 人附睾蛋白4(he4)用于评估muc16阳性癌症治疗的响应性的用途 |
| WO2018026742A1 (en) | 2016-08-01 | 2018-02-08 | Askgene Pharma Inc. | Novel antibody-albumin-drug conjugates (aadc) and methods for using them |
| CN108164512B (zh) | 2017-12-27 | 2021-05-25 | 沈阳药科大学 | 一类具有生物粘附作用的马来酰亚胺型前药及其在口服药物传递中的应用 |
| CN108187063B (zh) | 2018-01-09 | 2020-09-08 | 沈阳药科大学 | 白蛋白结合型抗肿瘤药-马来酰亚胺分子前药 |
-
2016
- 2016-12-09 SG SG11201804885TA patent/SG11201804885TA/en unknown
- 2016-12-09 MX MX2018006953A patent/MX2018006953A/es active IP Right Grant
- 2016-12-09 SM SM20210709T patent/SMT202100709T1/it unknown
- 2016-12-09 LT LTEPPCT/EP2016/080453T patent/LT3386997T/lt unknown
- 2016-12-09 HU HUE16822917A patent/HUE056897T2/hu unknown
- 2016-12-09 DK DK16822917.7T patent/DK3386997T3/da active
- 2016-12-09 CA CA3004630A patent/CA3004630A1/en active Pending
- 2016-12-09 RS RS20211187A patent/RS62412B1/sr unknown
- 2016-12-09 CN CN201680072428.4A patent/CN108368143B/zh active Active
- 2016-12-09 HR HRP20211466TT patent/HRP20211466T1/hr unknown
- 2016-12-09 JP JP2018529981A patent/JP6867652B2/ja active Active
- 2016-12-09 PT PT16822917T patent/PT3386997T/pt unknown
- 2016-12-09 US US16/060,559 patent/US10723748B2/en active Active
- 2016-12-09 ES ES16822917T patent/ES2898704T3/es active Active
- 2016-12-09 EP EP16822917.7A patent/EP3386997B1/en active Active
- 2016-12-09 IL IL259864A patent/IL259864B/en unknown
- 2016-12-09 PL PL16822917T patent/PL3386997T3/pl unknown
- 2016-12-09 AU AU2016367306A patent/AU2016367306B2/en active Active
- 2016-12-09 WO PCT/EP2016/080453 patent/WO2017097986A1/en active Application Filing
- 2016-12-09 SI SI201631342T patent/SI3386997T1/sl unknown
-
2020
- 2020-06-17 US US16/904,528 patent/US11572379B2/en active Active
-
2021
- 2021-09-27 CY CY20211100840T patent/CY1124529T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE056897T2 (hu) | 2022-03-28 |
| CN108368143B (zh) | 2022-02-01 |
| HRP20211466T1 (hr) | 2021-12-24 |
| IL259864A (en) | 2018-07-31 |
| JP6867652B2 (ja) | 2021-05-12 |
| SMT202100709T1 (it) | 2022-01-10 |
| PL3386997T3 (pl) | 2021-12-13 |
| CA3004630A1 (en) | 2017-06-15 |
| MX2018006953A (es) | 2019-05-16 |
| CN108368143A (zh) | 2018-08-03 |
| SG11201804885TA (en) | 2018-07-30 |
| EP3386997A1 (en) | 2018-10-17 |
| US20210002313A1 (en) | 2021-01-07 |
| JP2018538292A (ja) | 2018-12-27 |
| US20180354979A1 (en) | 2018-12-13 |
| US10723748B2 (en) | 2020-07-28 |
| ES2898704T3 (es) | 2022-03-08 |
| PT3386997T (pt) | 2021-11-04 |
| US11572379B2 (en) | 2023-02-07 |
| CY1124529T1 (el) | 2022-07-22 |
| IL259864B (en) | 2022-07-01 |
| AU2016367306B2 (en) | 2021-04-22 |
| AU2016367306A1 (en) | 2018-06-14 |
| RS62412B1 (sr) | 2021-10-29 |
| WO2017097986A1 (en) | 2017-06-15 |
| EP3386997B1 (en) | 2021-06-30 |
| DK3386997T3 (da) | 2021-09-20 |
| SI3386997T1 (sl) | 2021-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283733A (en) | Methods of cancer treatment using activated t cells | |
| PT3283527T (pt) | Terapêutica de combinação para o cancro | |
| HUE054012T2 (hu) | Kombinációs terápia rák ellen | |
| DK3580211T3 (da) | 2-heteroaryl-3-oxo-2,3-dihydropyridazin-4-carboxamider til behandling af cancer | |
| HUE059694T2 (hu) | Készítmény rák kezelésére | |
| DK3265421T3 (da) | Doseringssystem | |
| LT3594238T (lt) | Antikūno kompozicijos, skirtos navikų gydymui | |
| DK3262066T4 (da) | Genterapi | |
| KR20180084772A (ko) | 암 치료를 위한 조합 치료법 | |
| BR112018005409A2 (pt) | terapêutica de glicodirecionamento. | |
| EP3474854A4 (en) | DRUG ASSOCIATIONS FOR THE TREATMENT OF CANCER | |
| LT3386997T (lt) | Monomaleimidu funkcionalizuoti platinos junginiai, skirti vėžio terapijai | |
| EP3413927A4 (en) | CANCER THERAPY | |
| DK3393478T3 (da) | Kombinationsterapi | |
| LT3377094T (lt) | Susilpninto virulentiškumo bakterijos, skirtos piktybinių solidinių navikų gydymui | |
| LT3534885T (lt) | Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui | |
| EP3395436A4 (en) | MICRO REACTOR | |
| LT3383385T (lt) | Melflufeno dozavimo režimas vėžio atveju | |
| EP3362091A4 (en) | COMBINATION THERAPY | |
| DK3294769T3 (da) | Behandling for multipelt myelom (mm) | |
| DK3359555T3 (da) | Doseringsplaner | |
| EP3484477A4 (en) | CANCER TREATMENT | |
| DK3374357T3 (da) | Disubstituerede diaryloxybenzoheterodiazol-forbindelser | |
| DK3407909T3 (da) | Cancerbehandling | |
| DK3795130T3 (da) | Terapiapparat. |